A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

NCT00121628 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
184
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen